A new playbook caps a decade-long collaboration between Dassault Systèmes and the FDA, signaling the rise of in-silico clinical trials and a new era of medtech innovation.
Steve Levine
Table of contents
Stay up to date
Receive monthly updates on content you won’t want to miss
Subscribe
Register here to receive updates featuring our newest content.